Equities Analysts Issue Forecasts for ALLO Q1 Earnings
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – William Blair issued their Q1 2026 EPS estimates for shares of Allogene Therapeutics in a note issued to investors on Friday, March 14th. William Blair analyst S. Corwin expects that the company will post earnings of ($0.29) per share for the quarter. The consensus estimate for Allogene […]
